Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling

Temporary focal ischemia causes greater hemorrhagic transformation (HT) in diabetic Goto-Kakizaki (GK) rats, a model with increased cerebrovascular matrix metalloprotease (MMP) activity and tortuosity. The objective of the current study was to test the hypotheses that (1) diabetes-induced cerebrovas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cerebral blood flow and metabolism 2010-12, Vol.30 (12), p.1928-1938
Hauptverfasser: Elgebaly, Mostafa M, Prakash, Roshini, Li, Weiguo, Ogbi, Safia, Johnson, Maribeth H, Mezzetti, Erin M, Fagan, Susan C, Ergul, Adviye
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1938
container_issue 12
container_start_page 1928
container_title Journal of cerebral blood flow and metabolism
container_volume 30
creator Elgebaly, Mostafa M
Prakash, Roshini
Li, Weiguo
Ogbi, Safia
Johnson, Maribeth H
Mezzetti, Erin M
Fagan, Susan C
Ergul, Adviye
description Temporary focal ischemia causes greater hemorrhagic transformation (HT) in diabetic Goto-Kakizaki (GK) rats, a model with increased cerebrovascular matrix metalloprotease (MMP) activity and tortuosity. The objective of the current study was to test the hypotheses that (1) diabetes-induced cerebrovascular remodeling is MMP dependent and (2) prevention of vascular remodeling by glucose control or MMP inhibition reduces HT in diabetic stroke. Control and GK rats were treated with vehicle, metformin, or minocycline for 4 weeks, and indices of remodeling including vascular tortuosity index, lumen diameter, number of collaterals, and middle cerebral artery (MCA) MMP activity were measured. Additional animals were subjected to 3 hours MCA occlusion/21 hours reperfusion, and infarct size and HT were evaluated as indices of neurovascular injury. All remodeling markers including MMP-9 activity were increased in diabetes. Infarct size was smaller in minocycline-treated animals. Both metformin and minocycline reduced vascular remodeling and severity of HT in diabetes. These results provide evidence that diabetes-mediated stimulation of MMP-9 activity promotes cerebrovascular remodeling, which contributes to greater HT in diabetes. Metformin and minocycline offer vascular protection, which has important clinical implications for diabetes patients who are at a fourfold to sixfold higher risk for stroke.
doi_str_mv 10.1038/jcbfm.2010.120
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3002883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1038_jcbfm.2010.120</sage_id><sourcerecordid>2202449411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-2bf8d99e6f08f7b9e9703ccf7543c65ea9edbefc46b69ab08383d5618b8c4d913</originalsourceid><addsrcrecordid>eNqFkV1rFDEUhoModq3eeimDIF7IrMlkkkl6IUjrR6FFqR94FzKZkzVrZrImM2L_fTPudquCeBVCnvPmnPMg9JDgJcFUPF-b1vbLCs_3Ct9CC8KYLBtM-G20wFVDSt6ILwfoXkprjLGgjN1FBxXmvOaELlD3WSczeR2L9zGMYEYXhsINxYnTLYzOFB_GGL7BUXERPBTBFud6jO5ncQ6j9j5s5iKdoDyBDQwdDGOxD7yAPnTg3bC6j-5Y7RM82J2H6NPrVx-P35Zn796cHr88Kw0j9VhWrRWdlMAtFrZpJcgGU2Nsw2pqOAMtoWvBmpq3XOo2DyNoxzgRrTB1Jwk9RC-2uZup7aEzuZ2ovdpE1-t4qYJ26s-XwX1Vq_BDUYwrIWgOeLoLiOH7BGlUvUsGvNcDhCkpyWqORUXJf0mRPbAa1zyTj_8i12GKQ97DDFHCa9lkaLmFTAwpRbD7pglWs2j1S7SaRassOhc8-n3UPX5tNgNPdkD2ob2NejAu3XBUEtLIOejZlkt6BTet_ePbK-u9wS4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>815316497</pqid></control><display><type>article</type><title>Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SAGE Complete A-Z List</source><source>PubMed Central</source><creator>Elgebaly, Mostafa M ; Prakash, Roshini ; Li, Weiguo ; Ogbi, Safia ; Johnson, Maribeth H ; Mezzetti, Erin M ; Fagan, Susan C ; Ergul, Adviye</creator><creatorcontrib>Elgebaly, Mostafa M ; Prakash, Roshini ; Li, Weiguo ; Ogbi, Safia ; Johnson, Maribeth H ; Mezzetti, Erin M ; Fagan, Susan C ; Ergul, Adviye</creatorcontrib><description>Temporary focal ischemia causes greater hemorrhagic transformation (HT) in diabetic Goto-Kakizaki (GK) rats, a model with increased cerebrovascular matrix metalloprotease (MMP) activity and tortuosity. The objective of the current study was to test the hypotheses that (1) diabetes-induced cerebrovascular remodeling is MMP dependent and (2) prevention of vascular remodeling by glucose control or MMP inhibition reduces HT in diabetic stroke. Control and GK rats were treated with vehicle, metformin, or minocycline for 4 weeks, and indices of remodeling including vascular tortuosity index, lumen diameter, number of collaterals, and middle cerebral artery (MCA) MMP activity were measured. Additional animals were subjected to 3 hours MCA occlusion/21 hours reperfusion, and infarct size and HT were evaluated as indices of neurovascular injury. All remodeling markers including MMP-9 activity were increased in diabetes. Infarct size was smaller in minocycline-treated animals. Both metformin and minocycline reduced vascular remodeling and severity of HT in diabetes. These results provide evidence that diabetes-mediated stimulation of MMP-9 activity promotes cerebrovascular remodeling, which contributes to greater HT in diabetes. Metformin and minocycline offer vascular protection, which has important clinical implications for diabetes patients who are at a fourfold to sixfold higher risk for stroke.</description><identifier>ISSN: 0271-678X</identifier><identifier>EISSN: 1559-7016</identifier><identifier>DOI: 10.1038/jcbfm.2010.120</identifier><identifier>PMID: 20664613</identifier><identifier>CODEN: JCBMDN</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Animals ; Biological and medical sciences ; Brain Ischemia - enzymology ; Brain Ischemia - etiology ; Diabetes Complications - enzymology ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Male ; Matrix Metalloproteinases - metabolism ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Original ; Rats ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>Journal of cerebral blood flow and metabolism, 2010-12, Vol.30 (12), p.1928-1938</ispartof><rights>2010 ISCBFM</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Dec 2010</rights><rights>Copyright © 2010 International Society for Cerebral Blood Flow &amp; Metabolism, Inc. 2010 International Society for Cerebral Blood Flow &amp; Metabolism, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-2bf8d99e6f08f7b9e9703ccf7543c65ea9edbefc46b69ab08383d5618b8c4d913</citedby><cites>FETCH-LOGICAL-c514t-2bf8d99e6f08f7b9e9703ccf7543c65ea9edbefc46b69ab08383d5618b8c4d913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002883/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002883/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,21799,27903,27904,43600,43601,53769,53771</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23911790$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20664613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elgebaly, Mostafa M</creatorcontrib><creatorcontrib>Prakash, Roshini</creatorcontrib><creatorcontrib>Li, Weiguo</creatorcontrib><creatorcontrib>Ogbi, Safia</creatorcontrib><creatorcontrib>Johnson, Maribeth H</creatorcontrib><creatorcontrib>Mezzetti, Erin M</creatorcontrib><creatorcontrib>Fagan, Susan C</creatorcontrib><creatorcontrib>Ergul, Adviye</creatorcontrib><title>Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling</title><title>Journal of cerebral blood flow and metabolism</title><addtitle>J Cereb Blood Flow Metab</addtitle><description>Temporary focal ischemia causes greater hemorrhagic transformation (HT) in diabetic Goto-Kakizaki (GK) rats, a model with increased cerebrovascular matrix metalloprotease (MMP) activity and tortuosity. The objective of the current study was to test the hypotheses that (1) diabetes-induced cerebrovascular remodeling is MMP dependent and (2) prevention of vascular remodeling by glucose control or MMP inhibition reduces HT in diabetic stroke. Control and GK rats were treated with vehicle, metformin, or minocycline for 4 weeks, and indices of remodeling including vascular tortuosity index, lumen diameter, number of collaterals, and middle cerebral artery (MCA) MMP activity were measured. Additional animals were subjected to 3 hours MCA occlusion/21 hours reperfusion, and infarct size and HT were evaluated as indices of neurovascular injury. All remodeling markers including MMP-9 activity were increased in diabetes. Infarct size was smaller in minocycline-treated animals. Both metformin and minocycline reduced vascular remodeling and severity of HT in diabetes. These results provide evidence that diabetes-mediated stimulation of MMP-9 activity promotes cerebrovascular remodeling, which contributes to greater HT in diabetes. Metformin and minocycline offer vascular protection, which has important clinical implications for diabetes patients who are at a fourfold to sixfold higher risk for stroke.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain Ischemia - enzymology</subject><subject>Brain Ischemia - etiology</subject><subject>Diabetes Complications - enzymology</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Male</subject><subject>Matrix Metalloproteinases - metabolism</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Original</subject><subject>Rats</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>0271-678X</issn><issn>1559-7016</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkV1rFDEUhoModq3eeimDIF7IrMlkkkl6IUjrR6FFqR94FzKZkzVrZrImM2L_fTPudquCeBVCnvPmnPMg9JDgJcFUPF-b1vbLCs_3Ct9CC8KYLBtM-G20wFVDSt6ILwfoXkprjLGgjN1FBxXmvOaELlD3WSczeR2L9zGMYEYXhsINxYnTLYzOFB_GGL7BUXERPBTBFud6jO5ncQ6j9j5s5iKdoDyBDQwdDGOxD7yAPnTg3bC6j-5Y7RM82J2H6NPrVx-P35Zn796cHr88Kw0j9VhWrRWdlMAtFrZpJcgGU2Nsw2pqOAMtoWvBmpq3XOo2DyNoxzgRrTB1Jwk9RC-2uZup7aEzuZ2ovdpE1-t4qYJ26s-XwX1Vq_BDUYwrIWgOeLoLiOH7BGlUvUsGvNcDhCkpyWqORUXJf0mRPbAa1zyTj_8i12GKQ97DDFHCa9lkaLmFTAwpRbD7pglWs2j1S7SaRassOhc8-n3UPX5tNgNPdkD2ob2NejAu3XBUEtLIOejZlkt6BTet_ePbK-u9wS4</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Elgebaly, Mostafa M</creator><creator>Prakash, Roshini</creator><creator>Li, Weiguo</creator><creator>Ogbi, Safia</creator><creator>Johnson, Maribeth H</creator><creator>Mezzetti, Erin M</creator><creator>Fagan, Susan C</creator><creator>Ergul, Adviye</creator><general>SAGE Publications</general><general>Nature Publishing Group</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20101201</creationdate><title>Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling</title><author>Elgebaly, Mostafa M ; Prakash, Roshini ; Li, Weiguo ; Ogbi, Safia ; Johnson, Maribeth H ; Mezzetti, Erin M ; Fagan, Susan C ; Ergul, Adviye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-2bf8d99e6f08f7b9e9703ccf7543c65ea9edbefc46b69ab08383d5618b8c4d913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain Ischemia - enzymology</topic><topic>Brain Ischemia - etiology</topic><topic>Diabetes Complications - enzymology</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Male</topic><topic>Matrix Metalloproteinases - metabolism</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Original</topic><topic>Rats</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elgebaly, Mostafa M</creatorcontrib><creatorcontrib>Prakash, Roshini</creatorcontrib><creatorcontrib>Li, Weiguo</creatorcontrib><creatorcontrib>Ogbi, Safia</creatorcontrib><creatorcontrib>Johnson, Maribeth H</creatorcontrib><creatorcontrib>Mezzetti, Erin M</creatorcontrib><creatorcontrib>Fagan, Susan C</creatorcontrib><creatorcontrib>Ergul, Adviye</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cerebral blood flow and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elgebaly, Mostafa M</au><au>Prakash, Roshini</au><au>Li, Weiguo</au><au>Ogbi, Safia</au><au>Johnson, Maribeth H</au><au>Mezzetti, Erin M</au><au>Fagan, Susan C</au><au>Ergul, Adviye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling</atitle><jtitle>Journal of cerebral blood flow and metabolism</jtitle><addtitle>J Cereb Blood Flow Metab</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>30</volume><issue>12</issue><spage>1928</spage><epage>1938</epage><pages>1928-1938</pages><issn>0271-678X</issn><eissn>1559-7016</eissn><coden>JCBMDN</coden><abstract>Temporary focal ischemia causes greater hemorrhagic transformation (HT) in diabetic Goto-Kakizaki (GK) rats, a model with increased cerebrovascular matrix metalloprotease (MMP) activity and tortuosity. The objective of the current study was to test the hypotheses that (1) diabetes-induced cerebrovascular remodeling is MMP dependent and (2) prevention of vascular remodeling by glucose control or MMP inhibition reduces HT in diabetic stroke. Control and GK rats were treated with vehicle, metformin, or minocycline for 4 weeks, and indices of remodeling including vascular tortuosity index, lumen diameter, number of collaterals, and middle cerebral artery (MCA) MMP activity were measured. Additional animals were subjected to 3 hours MCA occlusion/21 hours reperfusion, and infarct size and HT were evaluated as indices of neurovascular injury. All remodeling markers including MMP-9 activity were increased in diabetes. Infarct size was smaller in minocycline-treated animals. Both metformin and minocycline reduced vascular remodeling and severity of HT in diabetes. These results provide evidence that diabetes-mediated stimulation of MMP-9 activity promotes cerebrovascular remodeling, which contributes to greater HT in diabetes. Metformin and minocycline offer vascular protection, which has important clinical implications for diabetes patients who are at a fourfold to sixfold higher risk for stroke.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>20664613</pmid><doi>10.1038/jcbfm.2010.120</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0271-678X
ispartof Journal of cerebral blood flow and metabolism, 2010-12, Vol.30 (12), p.1928-1938
issn 0271-678X
1559-7016
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3002883
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SAGE Complete A-Z List; PubMed Central
subjects Animals
Biological and medical sciences
Brain Ischemia - enzymology
Brain Ischemia - etiology
Diabetes Complications - enzymology
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Male
Matrix Metalloproteinases - metabolism
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Original
Rats
Vascular diseases and vascular malformations of the nervous system
title Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T10%3A29%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vascular%20Protection%20in%20Diabetic%20Stroke:%20Role%20of%20Matrix%20Metalloprotease-Dependent%20Vascular%20Remodeling&rft.jtitle=Journal%20of%20cerebral%20blood%20flow%20and%20metabolism&rft.au=Elgebaly,%20Mostafa%20M&rft.date=2010-12-01&rft.volume=30&rft.issue=12&rft.spage=1928&rft.epage=1938&rft.pages=1928-1938&rft.issn=0271-678X&rft.eissn=1559-7016&rft.coden=JCBMDN&rft_id=info:doi/10.1038/jcbfm.2010.120&rft_dat=%3Cproquest_pubme%3E2202449411%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=815316497&rft_id=info:pmid/20664613&rft_sage_id=10.1038_jcbfm.2010.120&rfr_iscdi=true